What You Ought to Know:
– Helix, a pacesetter in inhabitants genomics and precision well being, is asserting a brand new complete clinico-genomic digital registry of autoimmune illness sufferers.
– Consisting of over 23,000 people with situations corresponding to Lupus, Rheumatoid Arthritis (RA), Psoriasis, A number of Sclerosis (MS), Hashimoto’s illness, Crohn’s and lots of extra, it’s one of many largest autoimmune cohorts on this planet.
Helix Expands Autoimmune Analysis Capabilities with Clinico-Genomic Digital Registry
Helix, a pacesetter in inhabitants genomics, is advancing the combination of genomic information into affected person care and therapeutic growth. With autoimmune illnesses affecting 50 million Individuals and incidence charges rising for situations like Lupus, Inflammatory Bowel Illness, and Kind 1 Diabetes, Helix is increasing its dedication to autoimmune analysis.
Helix’s analysis ecosystem, constructed on 12 years of longitudinal medical information, consists of Entire Exome+® sequencing, demographic and medical claims information, and over 23,000 consented sufferers identified with situations corresponding to Rheumatoid Arthritis, Lupus, A number of Sclerosis, Psoriasis, Hashimoto’s illness, and Crohn’s. The registry additionally curates 15+ key autoimmune biomarkers, together with ANA, CRP, and ESR, offering a strong useful resource for finding out illness mechanisms, validating drug targets, and figuring out genetically and phenotypically focused affected person populations.
“We’re dedicated to uncovering the genetic foundation of autoimmune situations,” mentioned James Lu, M.D., Ph.D., CEO and co-founder of Helix. “With one of many largest autoimmune digital registries, we offer researchers with real-world genetic information to drive therapeutic breakthroughs. The rising prevalence of situations like celiac illness and A number of Sclerosis highlights the necessity for innovation.”
This registry is the newest addition to the Helix Analysis Community (HRN), North America’s largest and fastest-growing precision medical analysis community. Earlier this 12 months, Helix launched the world’s largest GLP-1 agonist digital registry. All HRN members consent to future analysis, making certain ongoing developments in precision drugs. By integrating genomic and medical insights, Helix is accelerating autoimmune analysis and advancing therapeutic discovery for thousands and thousands worldwide.
